All Stories

  1. Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson’s Disease

    Article • Journal of Parkinson s Disease, April 2021, IOS Press

    Dr Stuart H Isaacson

  2. Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson’s Disease Psychosis

    Article • Journal of Parkinson s Disease, October 2020, IOS Press

    Dr Stuart H Isaacson

  3. Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease

    Article • The Journal of Clinical Psychiatry, January 2020, Physicians Postgraduate Press, Inc

    Dr Stuart H Isaacson

  4. Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments

    Article • The Journal of Clinical Psychiatry, December 2019, Physicians Postgraduate Press, Inc

    Dr Stuart H Isaacson

  5. Changing the treatment paradigm for Parkinson’s disease psychosis with pimavanserin

    Article • Expert Review of Clinical Pharmacology, June 2019, Taylor & Francis

    Dr Stuart H Isaacson

  6. Long-term safety and efficacy of MYOBLOC® (rimabotulinumtoxinB) in the treatment of adult sialorrhea

    Article • Toxicon, December 2018, Elsevier

    Dr Stuart H Isaacson

  7. Myobloc® (rimabotulinumtoxinB) in the treatment of adult sialorrhea

    Article • Toxicon, December 2018, Elsevier

    Dr Stuart H Isaacson

  8. Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson’s disease: recommendations from an expert panel

    Article • Expert Review of Neurotherapeutics, July 2018, Taylor & Francis

    Dr Stuart H Isaacson

  9. Mysticol: A controlled study of myobloc in the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions

    Article • Toxicon, December 2016, Elsevier

    Dr Stuart H Isaacson

  10. Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303)

    Article • Journal of Parkinson s Disease, October 2016, IOS Press

    Dr Stuart H Isaacson

  11. Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

    Article • Movement Disorders Clinical Practice, May 2016, Wiley

    Dr Stuart H Isaacson

  12. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa

    Article • Vascular Health and Risk Management, April 2014, Taylor & Francis

    Dr Stuart H Isaacson

  13. Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson's Disease (NOH306A)

    Article • Journal of Parkinson s Disease, January 2014, IOS Press

    Dr Stuart H Isaacson

  14. Review: Improving symptom control in early Parkinson’s disease

    Article • Therapeutic Advances in Neurological Disorders, August 2009, SAGE Publications

    Dr Stuart H Isaacson

  15. Selective MAO-B inhibitors have low potential for the tyramine effect

    Article • Movement Disorders, November 2008, Wiley

    Dr Stuart H Isaacson

  16. The "Wearing Off" Phenomenon in Parkinson's Disease: Current Strategies for Optimizing Dopaminergic Therapy in Long-Term Care

    Article • The Consultant Pharmacist, November 2005, American Society of Consultant Pharmacists

    Dr Stuart H Isaacson